Search details
1.
Standardized Definitions for Cardiogenic Shock Research and Mechanical Circulatory Support Devices: Scientific Expert Panel From the Shock Academic Research Consortium (SHARC).
Circulation
; 148(14): 1113-1126, 2023 10 03.
Article
in English
| MEDLINE | ID: mdl-37782695
2.
Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease.
N Engl J Med
; 381(19): 1820-1830, 2019 11 07.
Article
in English
| MEDLINE | ID: mdl-31562798
3.
Antithrombotic regimens for percutaneous coronary intervention of the left main coronary artery: The EXCEL trial.
Catheter Cardiovasc Interv
; 97(5): 766-773, 2021 04 01.
Article
in English
| MEDLINE | ID: mdl-32181569
4.
Clinical Outcomes Before and After Complete Everolimus-Eluting Bioresorbable Scaffold Resorption: Five-Year Follow-Up From the ABSORB III Trial.
Circulation
; 140(23): 1895-1903, 2019 12 03.
Article
in English
| MEDLINE | ID: mdl-31553222
5.
Impact of large periprocedural myocardial infarction on mortality after percutaneous coronary intervention and coronary artery bypass grafting for left main disease: an analysis from the EXCEL trial.
Eur Heart J
; 40(24): 1930-1941, 2019 06 21.
Article
in English
| MEDLINE | ID: mdl-30919909
6.
Three-Year Outcomes With the Absorb Bioresorbable Scaffold: Individual-Patient-Data Meta-Analysis From the ABSORB Randomized Trials.
Circulation
; 137(5): 464-479, 2018 01 30.
Article
in English
| MEDLINE | ID: mdl-29089314
7.
Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease.
N Engl J Med
; 375(23): 2223-2235, 2016 12 08.
Article
in English
| MEDLINE | ID: mdl-27797291
8.
2-year outcomes with the Absorb bioresorbable scaffold for treatment of coronary artery disease: a systematic review and meta-analysis of seven randomised trials with an individual patient data substudy.
Lancet
; 390(10096): 760-772, 2017 Aug 19.
Article
in English
| MEDLINE | ID: mdl-28732815
9.
Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease.
N Engl J Med
; 373(20): 1905-15, 2015 Nov 12.
Article
in English
| MEDLINE | ID: mdl-26457558
10.
Sex disparities in acute myocardial infarction care and outcomes.
Catheter Cardiovasc Interv
; 92(5): E341-E347, 2018 11 01.
Article
in English
| MEDLINE | ID: mdl-29745453
11.
Long-term forecasting and comparison of mortality in the Evaluation of the Xience Everolimus Eluting Stent vs. Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) trial: prospective validation of the SYNTAX Score II.
Eur Heart J
; 36(20): 1231-41, 2015 May 21.
Article
in English
| MEDLINE | ID: mdl-25583761
12.
Cardiac safety research consortium "shock II" think tank report: Advancing practical approaches to generating evidence for the treatment of cardiogenic shock.
Am Heart J
; 230: 93-97, 2020 12.
Article
in English
| MEDLINE | ID: mdl-33011148
13.
Comparison of everolimus-eluting and sirolimus-eluting coronary stents: 1-year outcomes from the Randomized Evaluation of Sirolimus-eluting Versus Everolimus-eluting stent Trial (RESET).
Circulation
; 126(10): 1225-36, 2012 Sep 04.
Article
in English
| MEDLINE | ID: mdl-22824435
14.
Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease.
N Engl J Med
; 362(18): 1663-74, 2010 May 06.
Article
in English
| MEDLINE | ID: mdl-20445180
15.
Everolimus-eluting stents in patients undergoing percutaneous coronary intervention: final 3-year results of the Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With de Novo Native Coronary Artery Lesions trial.
Am Heart J
; 166(6): 1035-42, 2013 Dec.
Article
in English
| MEDLINE | ID: mdl-24268218
16.
An evidence-based review of the impact of periprocedural myocardial infarction in carotid revascularization.
Catheter Cardiovasc Interv
; 82(5): 709-14, 2013 Nov 01.
Article
in English
| MEDLINE | ID: mdl-23765902
17.
Clinical outcomes in real-world patients with acute myocardial infarction receiving XIENCE V® everolimus-eluting stents: one-year results from the XIENCE V USA study.
Catheter Cardiovasc Interv
; 82(4): E385-94, 2013 Oct 01.
Article
in English
| MEDLINE | ID: mdl-23172848
18.
Optimum technique to reduce risk of stent thrombosis - Authors' reply.
Lancet
; 388(10040): 127-8, 2016 Jul 09.
Article
in English
| MEDLINE | ID: mdl-27411875
19.
Long-term outcomes of percutaneous coronary intervention for in-stent restenosis among Medicare beneficiaries.
EuroIntervention
; 17(5): e380-e387, 2021 Aug 06.
Article
in English
| MEDLINE | ID: mdl-32863243
20.
Outcomes of Vascular Closure Device Use After Transfemoral Coronary Intervention: Insights From the EXCEL Trial.
J Invasive Cardiol
; 33(8): E619-E627, 2021 Aug.
Article
in English
| MEDLINE | ID: mdl-34170842